Genome-wide methylation sequencing identifies progression-related epigenetic drivers in myelodysplastic syndromes
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2041-4889
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Genome-wide methylation sequencing identifies progression-related epigenetic drivers in myelodysplastic syndromes ; volume:11 ; number:11 ; day:20 ; month:11 ; year:2020 ; pages:1-15 ; date:11.2020
Cell death & disease ; 11, Heft 11 (20.11.2020), 1-15, 11.2020
- Urheber
-
Zhou, Jing-dong
Zhang, Ting-juan
Xu, Zi-jun
Deng, Zhao-qun
Gu, Yu
Ma, Ji-chun
Wen, Xiang-mei
Leng, Jia-yan
Lin, Jiang
Chen, Su-ning
Qian, Jun
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41419-020-03213-2
- URN
-
urn:nbn:de:101:1-2020123121445291453237
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:38 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Zhou, Jing-dong
- Zhang, Ting-juan
- Xu, Zi-jun
- Deng, Zhao-qun
- Gu, Yu
- Ma, Ji-chun
- Wen, Xiang-mei
- Leng, Jia-yan
- Lin, Jiang
- Chen, Su-ning
- Qian, Jun
- SpringerLink (Online service)
Ähnliche Objekte (12)
Epigenetic therapy in myelodysplastic syndromes
Myelodysplastic syndromes
Myelodysplastic syndromes
Curcumin as an Epigenetic Therapeutic Agent in Myelodysplastic Syndromes (MDS)
Myelodysplastic syndromes : with 87 tabeles
Bone marrow apoptosis in myelodysplastic syndromes
Emerging Therapies for the Myelodysplastic Syndromes
Myelodysplastic syndromes: Where do we stand?
Bone marrow apoptosis in myelodysplastic syndromes
Myelodysplastic syndromes current treatment algorithm 2018
Epigenetic therapy of myelodysplastic syndromes connects to cellular differentiation independently of endogenous retroelement derepression
Drug development in higher-risk myelodysplastic syndromes
Epigenetic therapy in myelodysplastic syndromes
Myelodysplastic syndromes
Myelodysplastic syndromes
Curcumin as an Epigenetic Therapeutic Agent in Myelodysplastic Syndromes (MDS)
Myelodysplastic syndromes : with 87 tabeles
Bone marrow apoptosis in myelodysplastic syndromes
Emerging Therapies for the Myelodysplastic Syndromes
Myelodysplastic syndromes: Where do we stand?
Bone marrow apoptosis in myelodysplastic syndromes
Myelodysplastic syndromes current treatment algorithm 2018
Epigenetic therapy of myelodysplastic syndromes connects to cellular differentiation independently of endogenous retroelement derepression
Drug development in higher-risk myelodysplastic syndromes
Epigenetic therapy in myelodysplastic syndromes
Myelodysplastic syndromes
Myelodysplastic syndromes
Curcumin as an Epigenetic Therapeutic Agent in Myelodysplastic Syndromes (MDS)
Myelodysplastic syndromes : with 87 tabeles
Bone marrow apoptosis in myelodysplastic syndromes
Emerging Therapies for the Myelodysplastic Syndromes
Myelodysplastic syndromes: Where do we stand?
Bone marrow apoptosis in myelodysplastic syndromes
Myelodysplastic syndromes current treatment algorithm 2018
Epigenetic therapy of myelodysplastic syndromes connects to cellular differentiation independently of endogenous retroelement derepression